Annual report pursuant to Section 13 and 15(d)

Note 17 - Segment Reporting - Segment Financial Information (Details)

v3.6.0.2
Note 17 - Segment Reporting - Segment Financial Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue, Net $ 51,219,000 $ 62,383,000
Intercompany revenues
Gross profit 7,084,000 14,351,000
Research and Development Expense 2,046,000 2,302,000
Interest income 110,000 53,000
Interest expense (489,000) (489,000)
Interest expense-financing fees (108,000) (228,000)
Depreciation and amortization 4,165,000 3,717,000
Segment (loss) income before income taxes (16,257,000) 480,000
Income Tax Expense (Benefit) (2,994,000) 543,000
Loss from continuing operations (13,263,000) (63,000)
Segment assets(1) [1] 65,335,000 82,913,000
Expenditures for segment assets 436,000 623,000
Total debt 8,833,000 9,836,000
Treatment [Member]    
Revenue, Net 32,253,000 41,318,000
Intercompany revenues 40,000 113,000
Gross profit 4,015,000 10,910,000
Research and Development Expense 504,000 179,000
Interest income 3,000 6,000
Interest expense (29,000) (38,000)
Interest expense-financing fees (2,000)
Depreciation and amortization 3,451,000 2,949,000
Segment (loss) income before income taxes (10,119,000) [2] 7,101,000
Income Tax Expense (Benefit) (3,013,000) [2] 538,000
Loss from continuing operations (7,106,000) 6,563,000
Segment assets(1) [1] 32,482,000 46,307,000
Expenditures for segment assets 418,000 579,000
Total debt 23,000
Services [Member]    
Revenue, Net 18,966,000 21,065,000
Intercompany revenues 28,000 25,000
Gross profit 3,069,000 3,441,000
Research and Development Expense 38,000
Interest income
Interest expense (2,000)
Interest expense-financing fees
Depreciation and amortization 632,000 725,000
Segment (loss) income before income taxes 744,000 1,178,000
Income Tax Expense (Benefit)
Loss from continuing operations 744,000 1,178,000
Segment assets(1) [1] 8,105,000 9,481,000
Expenditures for segment assets 17,000 33,000
Total debt
Medical [Member]    
Revenue, Net
Intercompany revenues
Gross profit
Research and Development Expense 1,489,000 2,114,000
Interest income
Interest expense
Interest expense-financing fees
Depreciation and amortization
Segment (loss) income before income taxes (1,489,000) (2,114,000)
Income Tax Expense (Benefit)
Loss from continuing operations (1,489,000) (2,114,000)
Segment assets(1) [1] 382,000 1,793,000
Expenditures for segment assets 1,000
Total debt
Segments Total [Member]    
Revenue, Net [3] 51,219,000 62,383,000
Intercompany revenues 68,000 138,000
Gross profit 7,084,000 14,351,000
Research and Development Expense 2,031,000 2,293,000
Interest income 3,000 6,000
Interest expense (31,000) (38,000)
Interest expense-financing fees (2,000)
Depreciation and amortization 4,083,000 3,674,000
Segment (loss) income before income taxes (10,864,000) 6,165,000
Income Tax Expense (Benefit) (3,013,000) 538,000
Loss from continuing operations (7,851,000) 5,627,000
Segment assets(1) [1] 40,969,000 57,581,000
Expenditures for segment assets 436,000 612,000
Total debt 23,000
Corporate and Other [Member]    
Revenue, Net [4]
Intercompany revenues [4]
Gross profit [4]
Research and Development Expense [4] 15,000 9,000
Interest income [4] 107,000 47,000
Interest expense [4] (458,000) (451,000)
Interest expense-financing fees [4] (108,000) (226,000)
Depreciation and amortization [4] 82,000 43,000
Segment (loss) income before income taxes [4] (5,393,000) (5,685,000)
Income Tax Expense (Benefit) 19,000 5,000 [4]
Loss from continuing operations (5,412,000) (5,690,000) [4]
Segment assets(1) [1],[5] 24,366,000 25,332,000
Expenditures for segment assets [4] 11,000
Total debt [4],[6] $ 8,833,000 $ 9,813,000
[1] Segment assets have been adjusted for intercompany accounts to reflect actual assets for each segment.
[2] Amounts include tangible and intangible asset impairment losses of $1,816,000 and $8,288,000, respectively for the Company's M&EC subsidiary recorded in the second quarter of 2016 (see "Note 3 - M&EC Facility"). Also includes a tax benefit of approximately $3,203,000 recorded resulting from the intangible impairment loss recorded for our M&EC subsidiary.
[3] The Company performed services relating to waste generated by the federal government, either directly as a prime contractor or indirectly for others as a subcontractor to the federal government, representing approximately $27,354,000 or 53.4% of total revenue from continuing operations during 2016 and $36,105,000 or 57.9% of total revenue from continuing operations during 2015. The following reflects such revenue generated by our two segments: 2016 2015 Treatment $ 21,434,000 $ 30,130,000 Services 5,920,000 5,975,000 Total $ 27,354,000 $ 36,105,000
[4] Amounts reflect the activity for corporate headquarters not included in the segment information.
[5] Amount includes assets from our discontinued operations of $434,000 and $565,000, as of December 31, 2016 and 2015, respectively.
[6] Net of debt discount of ($0) and ($50,000) for 2016 and 2015, respectively, and net of debt issuance costs of ($151,000) and ($152,000) for 2016 and 2015, respectively (see "Note 10 - "Long-Term Debt" for additional information).